Bayer to Revise 2017 Outlook Amid Brazil, Currency Woes

By Monica Houston-Waesch Features Dow Jones Newswires

Bayer AG Friday warned it would take an earnings hit this year due to surprisingly high inventories at its Brazil operations, negative currency effects and a weak performance at its consumer health division.

Continue Reading Below

Bayer said adjusted earnings before interest, taxes, depreciation and amortization would be between 300 million-400 million euros ($342.4 million-$456.6 million) lower, due to high stocks of crop protection products at the end of the harvest season in Brazil.

"Bayer is also expecting earnings to be additionally impacted by unfavorable currency developments," it added.

In addition, business performance at its consumer health division "is weaker than previously expected," Bayer said.

Other divisions, including pharmaceuticals and Covestro are strong, while its animal health business is in line with expectations, Bayer said.

Bayer said it will adjust its 2017 forecasts for sales and earnings to be published with second quarter results.

Continue Reading Below

--Write to Monica Houston-Waesch at nikki.houston@wsj.com

(END) Dow Jones Newswires

June 30, 2017 04:08 ET (08:08 GMT)